Zhejiang Longsheng Group Co.,Ltd

XSSC:600352 Stock Report

Market Cap: CN¥33.3b

Zhejiang Longsheng GroupLtd Valuation

Is 600352 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 600352 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 600352 (CN¥10.25) is trading below our estimate of fair value (CN¥15.77)

Significantly Below Fair Value: 600352 is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 600352?

Key metric: As 600352 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 600352. This is calculated by dividing 600352's market cap by their current earnings.
What is 600352's PE Ratio?
PE Ratio16.8x
EarningsCN¥1.99b
Market CapCN¥33.35b

Price to Earnings Ratio vs Peers

How does 600352's PE Ratio compare to its peers?

The above table shows the PE ratio for 600352 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average38.9x
300037 Shenzhen Capchem Technology
34x29.0%CN¥31.7b
600378 Haohua Chemical Science & Technology
47.2x35.9%CN¥33.9b
600873 MeiHua Holdings GroupLtd
9.5x8.2%CN¥28.8b
688065 Cathay Biotech
64.7xn/aCN¥26.2b
600352 Zhejiang Longsheng GroupLtd
16.8x6.9%CN¥33.3b

Price-To-Earnings vs Peers: 600352 is good value based on its Price-To-Earnings Ratio (16.8x) compared to the peer average (39.6x).

Price to Earnings Ratio vs Industry

How does 600352's PE Ratio compare vs other companies in the CN Chemicals Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
No more companies available in this PE range
600352 16.8xIndustry Avg. 36.0xNo. of Companies40PE020406080100+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 600352 is good value based on its Price-To-Earnings Ratio (16.8x) compared to the CN Chemicals industry average (35.6x).

Price to Earnings Ratio vs Fair Ratio

What is 600352's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

600352 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio16.8x
Fair PE Ratio16.2x

Price-To-Earnings vs Fair Ratio: 600352 is expensive based on its Price-To-Earnings Ratio (16.8x) compared to the estimated Fair Price-To-Earnings Ratio (16.2x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 600352 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentCN¥10.25
CN¥11.89
+16.0%
6.9%CN¥12.84CN¥10.83n/a3
Nov ’25CN¥10.15
CN¥11.89
+17.1%
6.9%CN¥12.84CN¥10.83n/a3
Oct ’25CN¥10.52
CN¥11.34
+7.8%
13.8%CN¥12.84CN¥9.18n/a3
Sep ’25CN¥9.11
CN¥11.34
+24.5%
13.8%CN¥12.84CN¥9.18n/a3
Aug ’25CN¥8.87
CN¥11.61
+30.9%
10.3%CN¥12.84CN¥10.00n/a3
Jul ’25CN¥8.70
CN¥11.61
+33.5%
10.3%CN¥12.84CN¥10.00n/a3
Jun ’25CN¥8.84
CN¥11.61
+31.4%
10.3%CN¥12.84CN¥10.00n/a3
May ’25CN¥9.15
CN¥10.35
+13.1%
3.4%CN¥10.70CN¥10.00n/a2
Mar ’25CN¥8.56
CN¥10.53
+23.0%
1.7%CN¥10.70CN¥10.35n/a2
Feb ’25CN¥7.73
CN¥10.53
+36.2%
1.7%CN¥10.70CN¥10.35n/a2
Jan ’25CN¥8.40
CN¥10.53
+25.3%
1.7%CN¥10.70CN¥10.35n/a2
Dec ’24CN¥8.68
CN¥11.68
+34.6%
14.1%CN¥14.00CN¥10.35n/a3
Nov ’24CN¥8.91
CN¥11.68
+31.1%
14.1%CN¥14.00CN¥10.35CN¥10.153
Oct ’24CN¥9.29
CN¥11.68
+25.8%
14.1%CN¥14.00CN¥10.35CN¥10.523
Sep ’24CN¥9.29
CN¥11.68
+25.8%
14.1%CN¥14.00CN¥10.35CN¥9.113
Aug ’24CN¥9.79
CN¥12.65
+29.2%
7.7%CN¥14.00CN¥11.76CN¥8.873
Jul ’24CN¥9.35
CN¥12.65
+35.3%
7.7%CN¥14.00CN¥11.76CN¥8.703
Jun ’24CN¥9.42
CN¥12.65
+34.3%
7.7%CN¥14.00CN¥11.76CN¥8.843
May ’24CN¥9.58
CN¥11.98
+25.1%
1.8%CN¥12.20CN¥11.76CN¥9.152
Apr ’24CN¥10.27
CN¥10.65
+3.7%
14.6%CN¥12.20CN¥9.10CN¥8.612
Mar ’24CN¥10.43
CN¥10.83
+3.9%
11.9%CN¥12.20CN¥9.10CN¥8.563
Feb ’24CN¥10.08
CN¥10.83
+7.5%
11.9%CN¥12.20CN¥9.10CN¥7.733
Jan ’24CN¥9.90
CN¥10.83
+9.4%
11.9%CN¥12.20CN¥9.10CN¥8.403
Dec ’23CN¥9.86
CN¥10.83
+9.9%
11.9%CN¥12.20CN¥9.10CN¥8.683
Nov ’23CN¥9.13
CN¥11.26
+23.3%
15.9%CN¥13.47CN¥9.10CN¥8.913

Analyst Forecast: Target price is less than 20% higher than the current share price.

Discover undervalued companies

ValiantLtd

CN¥9.7b

Produces and sells chemical materials worldwide.

2643

CN¥10.46

7D

-4.4%

1Y

-37.9%

Chifeng Jilong Gold MiningLtd

CN¥28.2b

Operates as a gold and non-ferrous metal mining company.

600988

CN¥17.11

7D

-1.4%

1Y

22.3%

MeiHua Holdings GroupLtd

CN¥28.8b

A synthetic biology company, provides amino acid nutrition and health solutions in China and internationally.

600873

CN¥10.11

7D

-2.9%

1Y

6.1%